These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 26595091)

  • 1. The role of secukinumab in the treatment of ankylosing spondylitis.
    Shah R; Perry L; Deodhar A
    Immunotherapy; 2015; 7(12):1241-7. PubMed ID: 26595091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secukinumab: A Review in Ankylosing Spondylitis.
    Blair HA; Dhillon S
    Drugs; 2016 Jul; 76(10):1023-30. PubMed ID: 27255593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of investigational new drugs for treating ankylosing spondylitis.
    Wendling D
    Expert Opin Investig Drugs; 2016; 25(1):95-104. PubMed ID: 26561014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study.
    Sieper J; Deodhar A; Marzo-Ortega H; Aelion JA; Blanco R; Jui-Cheng T; Andersson M; Porter B; Richards HB;
    Ann Rheum Dis; 2017 Mar; 76(3):571-592. PubMed ID: 27582421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secukinumab (AIN457) in the treatment of ankylosing spondylitis.
    Braun J; Baraliakos X; Kiltz U
    Expert Opin Biol Ther; 2016; 16(5):711-22. PubMed ID: 26982813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitis.
    Wendling D; Verhoeven F; Prati C
    Expert Opin Biol Ther; 2019 Jan; 19(1):55-64. PubMed ID: 30500270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New treatment targets for axial spondyloarthritis.
    Sieper J
    Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii38-ii42. PubMed ID: 27856659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secukinumab: A Review in Ankylosing Spondylitis.
    Blair HA
    Drugs; 2019 Mar; 79(4):433-443. PubMed ID: 30793255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budget impact analysis of secukinumab versus adalimumab in the treatment of ankylosing spondylitis.
    Purmonen T; Törmälehto S; Wahlman H; Puolakka K
    J Med Econ; 2019 Feb; 22(2):151-157. PubMed ID: 30474450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials.
    Toussirot E; Vauchy C; Binda D; Michel F
    Drug Des Devel Ther; 2016; 10():2087-94. PubMed ID: 27445459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatment options and emerging drugs for axial spondyloarthritis: biological and targeted synthetic agents.
    Toussirot E
    Expert Opin Pharmacother; 2017 Feb; 18(3):275-282. PubMed ID: 28099816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secukinumab for rheumatology: development and its potential place in therapy.
    Koenders MI; van den Berg WB
    Drug Des Devel Ther; 2016; 10():2069-80. PubMed ID: 27445458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New evidence on the management of spondyloarthritis.
    Sieper J; Poddubnyy D
    Nat Rev Rheumatol; 2016 May; 12(5):282-95. PubMed ID: 27052489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologics in spondyloarthritis: TNFα inhibitors and other agents.
    Toussirot É
    Immunotherapy; 2015; 7(6):669-81. PubMed ID: 26058432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis.
    Henderson C; Davis JC
    Nat Clin Pract Rheumatol; 2006 Apr; 2(4):211-8. PubMed ID: 16932687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vertebral sarcoid mimicking ankylosing spondylitis or just a co-incidence?
    Malaviya AN; Sawhney S; Kapoor S; Garg S
    J Assoc Physicians India; 2010 Nov; 58():709-11. PubMed ID: 21510471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked reduction of sacroiliac joint inflammation on magnetic resonance imaging in a patient with ankylosing spondylitis after rituximab treatment.
    Huang Y; Cheng F; Zhang X; Tang J
    J Rheumatol; 2011 Sep; 38(9):2083-4. PubMed ID: 21885528
    [No Abstract]   [Full Text] [Related]  

  • 18. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis.
    Rudwaleit M; Schwarzlose S; Hilgert ES; Listing J; Braun J; Sieper J
    Ann Rheum Dis; 2008 Sep; 67(9):1276-81. PubMed ID: 18006539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The advent of IL-17A blockade in ankylosing spondylitis: secukinumab, ixekizumab and beyond.
    Dubash S; Bridgewood C; McGonagle D; Marzo-Ortega H
    Expert Rev Clin Immunol; 2019 Feb; 15(2):123-134. PubMed ID: 30576610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of ankylosing spondylitis (Bechterew disease)].
    Rudwaleit M; Sieper J
    Dtsch Med Wochenschr; 2005 Aug; 130(33):1882-6. PubMed ID: 16118732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.